We here report on non-equilibrium targeted Molecular Dynamics simulations as tool for the estimation of protein-ligand unbinding kinetics. With this method, we furthermore investigate the molecular basis determining unbinding rates, correlating simulations with experimental data from SPR kinetics measurements and X-ray crystallography on two small molecule compound libraries show that understanding the unbinding pathway and the protein-ligand interactions along this path is crucial for the prediction of small molecule ligands with defined unbinding kinetics.
Introduction
While rational drug design traditionally focuses on the optimization of binding affinity of compounds to target proteins, optimization of target binding kinetics is emerging as a new paradigm in drug discovery. [1] [2] [3] [4] [5] [6] [7] Often, drugs with optimized binding kinetics exhibit better efficacy profiles and reduced off-target toxicity, 1, 8 and thus are more likely to pass later clinical phases. 9 However, while the prerequisites for the rational design of high affinity drugs are well investigated, 10 the rational optimization of kinetic parameters of small molecules is in its early stages. 11, 12 Molecular determinants believed to be important in the modulation of binding kinetics include ligand molecular size, hydrophobic effects, electrostatic interactions, and conformational fluctuations. 4, 11 Recent reports further highlight the importance of protein-bound water molecules 12 and of protein internal electrostatic interactions. 13 However, the exact contribution and extend of each of these properties still needs to be further elucidated.
In order to gain a systematic understanding of the impact of different molecular discriminants on binding kinetics, and thus help to establish a knowledge basis necessary for rational design of compounds with desired kinetics, we performed a combined experimental and theoretical analysis on the dynamics of unbinding of two series of compounds with different chemical scaffolds (see Figure 1A ) bound to the ATP-binding N-terminal domain of the chaperone heat shock protein 90 (Hsp90, Figure 1B ), [14] [15] [16] which is a well-known target for anti-cancer drugs. 14, [17] [18] [19] Based on data shared within the Kinetics for Drug Discovery consortium (K4DD, www.k4dd.eu) 7, 20, 21 and preexisting data sets, 19, 22, 23 we included a total of 26 compounds in the present analysis, which are listed in Table S1 . Additionally, we determined by X-Ray crystallography the structures of two further protein-ligand complexes (see Tables S1 and S3) , and measured ligand binding kinetics and affinities of three further compounds via surface plasmon resonance (SPR). In detail, we investigated fourteen compounds with resorcinol backbone (compounds 1a-1n, see Figure S1 ; amongst them the Hsp90 inhibitor Ganetespib 24 1c), ten compounds with N-heterocycle functionalities 19 (compounds 2a-2k, see Figure S2 ), and the macrocyclic lactam Hsp90 inhibitor 17-DMAG 18 17. Figure 1B displays an overview of the N-terminal domain of Hsp90 with bound compound 1f. The binding site is located close to the protein surface, and exhibits two different conformations of the adjacent amino acids 102-114. These residues either form a helix conformation (helix 3) or a loop conformation, which was proposed to affect unbinding kinetics. To assess the molecular mechanisms of unbinding in Hsp90, we performed targeted molecular dynamics (TMD) simulations. [25] [26] [27] In brief, this method uses a holonomic constraint as an additional force in the simulations to push the ligand out of the binding site with a constant velocity. The constraint force is calculated via a Lagrange's equation of motion of the 1 st kind and updated each time step to move the ligand to a position that is in agreement with the preset constant velocity.
Integrating this force along the pathway yields the work performed to remove the ligand (see Supplementary Information for additional details). We focus our analysis on the contributions to unbinding kinetics, as unbinding events are easier to calculate than binding events. 28 As we almost exclusively use protein/ligand crystal structures with positions of protein-internal water molecules being resolved, we have an excellent structural basis for carrying out such simulations. ACN; Gradient: 5.5 min; Flow-rate: 2.4 ml/min; UV detection: 220 nm. 1 H NMR spectra were recorded at 300 K unless otherwise specified using a Bruker Avance DPX 300, AV 400, DPX 500 spectrometer (TMS as an internal standard). 1 H NMR chemical shifts are reported in parts per million (ppm). 1 H NMR data is reported as chemical shift (dH), relative integral, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, ddd = doublet of doublet of doublets, dt = doublet of triplets, td = triplet of doublets, tt = triplet of triplets, qd = quartet of doublets) and coupling constant (J Hz). All of the compounds reported in the manuscript have a purity ≥95% unless noted otherwise. Analytical data for new compounds is provided in Table S2 .
Methods

Chemistry
Crystallization and Structure Determination for compound 2d: A hexa-histidine tagged Nterminal fragment of Hsp90 (18-223) (NP_005339) was expressed and purified as described in ref. 20 . Crystallization conditions are also described in ref. 20 . Datasets were collected in-house on a Rigaku HF-007 rotating anode generator and a MAR CCD detector and in the synchrotron.
Diffraction data were processed with either XDS 30 or MOSFLM. 31 The structures were solved by the molecular replacement method using one set of coordinates of N-HSP90 available in the Protein Data Bank (pdb code: 1YER). The structures were refined using either CNX, 32 REFMAC5 33 or AUTOBUSTER program packages, 34 ligands were placed manually, and the structural models were manually rebuilt using either TURBO-FRODO (www.afmb.univ-mrs.fr/-TURBO) or COOT 35 . Final validation checks were performed using MOLPROBITY.
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Crystallization and Structure Determination for compound 2j: A hexa-histidine tagged Nterminal fragment of Hsp90 (9-236) (NP_005339) was expressed and purified by Instituto de
Biologia Experimental e Tecnológica (Lisbon, Portugal), according to previously described protocols. 19 The crystallization conditions are essentially the same as those described in refs. 7 and 19. Datasets were collected at the SLS synchrotron and processed with the XDS software package. 30 The structures were solved by molecular replacement with Phaser and refined either with CNX7 or BUSTER8. Model building was performed in Coot9, with inhibitors and water sites fitted into the initial |Fo|-|Fc| map. Data set statistics for new crystal structures are given in Table   S3 in the Supplementary Information.
Surface Plasmon Resonance (SPR) of compounds 2a, 2d and 2j: SPR measurements were performed on a Biacore 4000 instrument from GE Healthcare as previously described in refs. 7, 20 .
Briefly, recombinant N-HSP90 with 17-Desmethoxy-17-N,N-dimethylaminoethylaminogeldanamycin ( 17-DMAG, Merck Millipore) was immobilized on a Biacore CM5 chip at 25°C at a flow rate of 10 µL/min using amine coupling at pH 4.50 according to Biacore's standard protocol. Table S1 ). Ligand parameters were created with antechamber 41 and acpype 42 using GAFF parameters and AM1-BCC charges. 43, 44 Protein/ligand crystal structures together with present crystal water molecules were centered in a cubic box with 7 nm side length, missing protons added, protonated, solvated, and sodium ions added to ensure a charge neutral simulation box. Protonation states of amino acids were determined by propka. 45 Ligand charge states were selected according to literature pka values. 46, 47 In case of compounds 1j and 2a-k, in which protonable nitrogen atoms are found close to Asp93 and thus potentially could exhibit a different pka due to formation of salt bridges and/or strong hydrogen bonds, we performed QM calculations to obtain the correct protonation state: following earlier works, 46 we extracted the Asp93 side chain, appropriate ring fragments of the ligands carrying the protonable nitrogen atoms and water molecules between ligand fragments and the Asp93 side chain. In addition, we extracted a water molecule far from the binding site to carry an excess proton to keep the QM box charge neutral if necessary. Applying position constraints to atoms linking the extracted fragments to the removed backbone and side chains as well to the additional water molecule in such a way that their orientation remained close to crystal structures, we then optimized the QM systems subsequently at the HF/6-31G*, HF/6-31++G** and B3LYP/6-31++G** level using Orca. 47 For compounds 2a-2k, if the ligand fragment was capable to protonate Asp93, we chose the deprotonated form of the ligand, otherwise the protonated form. The list of resulting protonation states is given in Table S1 .
For compound 1j, which does not exhibit a direct salt bridge with Asp93, we chose the protonated form due to a lower final total system energy.
TMD calculations:
Simulations were carried out with PME 48 for electrostatics (minimal real space cut-off of 1 nm) and a van der Waals cut-off of 1 nm. Hydrogen atom bonds were constrained via the LINCS 49 algorithm. The prepared systems were first minimized with the conjugate gradient method, and subjected to a short equilibration runs in the NPT ensemble at 300 K and 1 bar, using the Berendsen thermostat and barostat, 50 with an integration step size of 2 fs and a trajectory length of 100 ps. For each ligand, 30 statistically independent equilibration runs were performed, in which differed velocity distributions were attributed to the minimized systems. Non-equilibrium TMD calculations using the Gromacs PULL code in constraint mode were then carried out by continuing the 30 independent equilibration runs for 200 ps in the NPT ensemble at 300 K and 1 bar, using the Nosé-Hoover thermostat 51, 52 and Parrinello-Rahman barostat, 53 with a fixed constraint velocity of 0.01 nm/ps and an integration step size of 1 fs. Constraint pseudoforces were written out for each time step. The 1 st reference group for COM pulling along path 1 consisted of all C(alpha) atoms of the beta-sheet forming the ligand binding site (see Fig. S3 ) and of all C(alpha) atoms of helix 1 for path 2, the 2 nd group was formed by the ligand heavy atoms. Trajectory evaluation was then carried out with Gromacs tools, and data evaluation in Python using numpy and scipy libraries. Figure   S3 ). Figure S4A displays the resulting free energy surface for compounds 1b, 1g, and 1l, which is in good general agreement with free energy curves for other Hsp90 binding ligands obtained by umbrella sampling. 29 The three investigated compounds exhibit 1-2 free energy barriers between the ligand bound and unbound state. Interpreting the shape and peak height by means of the Eyring equation 57 for rate constants, ,
with the friction-dependent prefactor k, the inverse temperature b = 1/RT and the free energy difference between bound state and unbinding transition state DG ≠ , we find a good qualitative agreement with the respective koff constants: 1l effectively does not exhibit a barrier, but a slope between bound and unbound state, and consequently exhibits the fastest unbinding of the three test
compounds. 1b and 1g exhibit a comparable transition barrier of ca. 65 kJ/mol ( Figure S4 ).
However, the barrier of 1b is broader than the one of 1g, and its maximum is found at 0.7 nm vs.
0.65 nm for 1g. Furthermore, 1b possesses a 2 nd small barrier at 1.8 nm. 1i should therefore unbind faster than 1l, but slower than 1b. These overall shapes are in good agreement with the experimental observation that 1b is exhibits the slowest unbinding of the three test compounds (see Table S1 ).
The main problem we faced when applying stationary TI calculations was the large number of necessary equilibration points along the unbinding pathway that need several nanoseconds of equilibration for reliable determination of the free energy surface, 58 significantly raising the computational cost for investigating a large set of compounds. Furthermore, in our two investigated compound groups, about half of all compounds exhibit two possible protonation states (1a, 17, 1j
and the full series 2). As an example, the morpholine side chain in 1aa (pKa ≈ 10) 59 can exist in a protonated state with a charge of +1 e (see Figure 1C ), or in a deprotonated state 1a with a charge of 0 e. All ligands in compound group 2 are bound to the protein by a hydrogen bond between nitrogen atoms in aromatic rings (pka range of ca. 3-5) 60 and Asp93 (see Figure S5 ), or via highly polarized water molecules mediating this contact. 61 Assigning the correct protonation state for such protein-ligand-water complexes is a challenging task, as the protein environment can significantly alter pKa values. 61, 62 To avoid a bias from wrongly chosen charge states, we needed a method that allowed us to carry out simulations of multiple compounds in 2-3 possible protonation states, with TI calculations simply being too inefficient for this task.
Surprisingly, when we looked at the mean non-equilibrium work profiles <W> from simulations necessary to generate start coordinates for TI calculations (see Figure S4B ), we found that the difference in <W> at the end of simulations qualitatively matches the order of unbinding constants of compounds 1b, 1g, and 1l. Furthermore, we observed that differences in <W> between compounds ( Figure S4C ) appear at positions where the DG curve from TI exhibits local maxima.
Furthermore, <W> converges rapidly within already n=30 independent trajectories (see Figure S6 ).
We thus evaluated a possible correlation between non-equilibrium TMD work <W> and experimentally determined koff constants using the full investigated compound set comprising all possible protonation states, as displayed in Figure S7A . As in the case with compounds 1b, 1g, and 1l, we observe a qualitative agreement between <W>(TMD) and koff, that appears to follow a linear dependency, with ligands requiring a large <W> being slowly unbinding compounds. Such a linear dependence can be expected for equilibrium ∆G ≠ in form of a linear free energy relationship, 63 but is surprisingly present in our non-equilibrium simulations, as well, and points to a connection between non-equilibrium work and the underlying equilibrium free energy profile. According to the Jarzynski equality, 64 (
with dissipative work Wdiss. Based on the mentioned increase of <W> at transition states ∆G ≠ (cf. Figure S4C ) and taking into account that we perform simulations in deep non-equilibrium (<W> is much larger than DG), we postulate that we do not observe system relaxation after crossing over the transition states, and thus .
Introducing Equation (3) in (1), we obtain (4) with , which serves as a basis of understanding the apparent linear nonequilibrium energy relationship. C effectively is a function of b, but in the following is treated as an independent fit factor, as we otherwise encountered instabilities in non-linear curve fitting. In the following, we approximate C to be constant, which is only valid in the case that the friction during unbinding is the same for all ligands. We proceeded carrying out TMD simulations in strict non-equilibrium with the full compound groups 1 and 2, with protonation states derived from literature 59, 60 or QM calculations (cf. Methods for details and Figure S1 and S2 for an overview of all employed ligand structures), and used the resulting mean work <W> as unbinding scores. 56 Fitting Equation (4) to the full data set on nonequilibrium works <W> as displayed in Fig. S7A , we again observe a qualitative agreement between <W> and experimental koff that can be rationalized as a linear dependency, although with a low Pearson's correlation coefficient of R 2 = 0.39. It appears that for the full set of compounds, assuming C in Eq. (4) to be constant is not a good approximation. We thus searched for physicochemical, reasonable categories within the initial data. Based on differences in helix-ligand and loop-ligand contact dynamics, 65 we separated the compounds according to helix-and loopbinding compounds (see Fig. S7B ), resulting in an improved R 2 = 0.59 for loop-binding compounds, but at an expense of R 2 = 0.18 for helix-binding compounds. We further separated the sets according to protein conformations into compound sets 1 (only taking resorcinol scaffolds into account) and 2 as displayed in Fig. S7C . In the case of group 1 compounds, this improved the R 2 = 0.80, and lead to a moderate R 2 =0.54 for loop-binding compounds. Series 2 does not experience the split, as all contained compounds bind to the helix conformation. Fitting Equation (4) to this series however resulted only in a low R 2 = 0.39. To achieve a better agreement of Equation (4) and <W>(TMD) for group 2, we postulate that some of the protonation states used in our calculations either are not correctly predicted by our QM calculations or change during unbinding due to transient protonation state changes. By iterative exclusion of states, which contain the largest residual (i.e. are farthest apart from the fit model), we searched for a combination of data points that follows equation (4) and yields a maximal R 2 . The results are presented in Figure 2A and S7C:
the postulate significantly improved the agreement between theoretical results and our theoretical model (R 2 = 0.87). We thus propose that the protonation state of a given compound during unbinding may be inferred as the state, which is in best agreement with the linear regression in the <W>-koff correlation of the whole compound series.
To assess if <W>(TMD) is a suitable score for a small koff, we calculated receiver operating characteristic (ROC) curves characterized by the respective area under curve (AUC) for the given data set. 66, 67 While the application to both full and protein conformation-separated data set yielded only random results (AUC ≈ 0.5), resorcinol compounds 1 after conformation separation resulted in a moderate to good prediction of slowly unbinding compounds (AUC = 0.72 for loop compounds and 0.81 for helix binding compounds). However, in the case of compound group 2, <W>(TMD)
is a bad predictor, while it is slightly improved over random selection for the optimal linear fit selection of ligands (AUC = 0.64). In this respect, <W>(TMD) faces similar problems with scaffold dependency like common affinity prediction-oriented docking, 68 but may indeed serve as a preselection criterion for slow unbinding compounds for suitable targets and ligands.
As all the calculations reported above took only unbinding along path 1 into account, we needed to assess if other possible unbinding pathways exist. Kokh et al. showed that two routes out of the binding site of the Hsp90 N-terminus exist, 20 the first one being path 1, and the second being found between helix 3 and the central b-sheet (path 2 in Fig. S3 ). Testing both pathways with 1a and 2a/2aa, we found that path 1 requires significantly less work for pushing the ligand into the solvent than path 2 (see Table S4 ), making it the most likely unbinding pathway. Furthermore, this pathway leads past Leu107, which has been implicated by point mutation experiments to affect unbinding kinetics.
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Influence of protein conformation and electrostatics on group 1 unbinding rates. As a starting point for investigating molecular effects influencing unbinding rates, we focused on a dependence on helix/loop 3 conformation as implied by our analysis in Fig 2. For helix binding compounds it was proposed that entropic contributions from protein flexibility play a significant role in the determination of binding affinities. 7 Indeed, helix binding compounds with decreasing koff display an increasing unbinding <W>, which can be interpreted as stronger resistance from the protein against the constraint force acting on ligands, correlating with a decreased protein flexibility.
As can be seen in Fig. 2 , the protonated ligand 17a and 1ja result in a slightly higher <W> than the neutral forms. This finding is consistent with the structure of the protein/ligand complexes, e.g., as the resulting ammonium moiety in 17a is found close to Asp54 (see Fig. S8 ), allowing the formation of a salt bridge (N-O distances of 2.8 Å). Indeed, enthalpic contributions comprising electrostatic interactions were found to be key factors in determining koff in loop binders. 7 However, the presence of a charge on the protein does not necessarily lead directly to an increased koff, as can be seen in the case of compound 1a: here, both charged state 1a and neutral state 1aa exhibit a comparable <W> due to an increased distance of 4.7 Å between Asp54 and the protonable morpholine moiety in 1a ( Figure S9 ). We conclude that within our investigated compound set, ligand charge slows down unbinding kinetics in loop binding compounds. 
Impact of resorcinol conformation on unbinding kinetics. Having identified electrostatic
interactions between protein and ligand as discriminator for ligand unbinding kinetics, we performed an analysis of ligand conformational changes during unbinding. We used the ligand radius of gyration as observable, i.e., the average distance of all ligand atoms from their common center of mass, and compared the different radii with the natural logarithm of the experimentally determined koff. For helix-binding compounds shown in Fig. 3A , we obtain a weak linear correlation (R 2 = 0.30) between differences in radii during unbinding and the average radii in the unbound state (i.e., during the 4 th quarter of the simulation): compounds, which bind to the protein in or need to pass through an extended conformation appear to unbind slowly. This result can be rationalized as an entropic contribution to unbinding kinetics: the conformational space of flexible ligands becomes restricted during unbinding, which causes an entropic penalty, turning unbinding less probable.
In loop conformation binding compounds (Figure 3B ), the overall radius of gyration (calculated for the unbound state) may decide the unbinding rate, though the agreement between linear fit and actual data again is weak (R 2 = 0.63). Compound 1a is significantly larger than the remaining loop binders. Loop-binding compounds appear therefore to unbind slowly if they exhibit strong van der Waals interactions with the protein, which again is in agreement with the importance of enthalpic contributions for loop binders. We note that the hypotheses listed in the previous two paragraphs need to be taken with a grain of salt, as they are only weakly supported by our data, and mostly depend on a single data point (1n for helix binders and 1a for loop binders).
Ligand charges and conformation effects in compound group 2. Figure 3C shows that for the N-heterocycle series 2, the best agreement between radii of gyration changes and experimental unbinding constants for slowly unbinding compounds (i.e., when ignoring compounds 2i, 2j and 2k) is found for the absolute change in radius of gyration (their exclusion increases R 2 from 0.37 to 0.60). Such outliers may be related to the large variation of side chains within the series, and 2j
and 2k exhibit a unique scaffold. In other words, slowly unbinding compounds from group 2 appear to be rigid structures, while fast unbinding compounds can change their conformation, irrespective of if they pass through extended or contracted states. Although the binding mode of series 1 and 2 helix binders is quite similar (cf. Figure S5 ), the source of this difference lies in the individual flexibilities of scaffolds: the resorcinol scaffold is branching off the variable side chains at an angle of 120˚ with a low distance between branching points, and the series contains several flexible side chains, leading to a wide range of conformations that they can access. The N-heterocycle compounds are based on large and rigid scaffolds (fluorenyl and indazole moieties), which holds true for side chain moieties, as well. Series 2 compounds therefore are enthalpically locked in their conformation, and either extending or contracting their overall radius will be energetically unfavorable. We therefore conclude that the detailed connection between conformational changes and unbinding kinetics for the investigated Hsp90 ligands is dependent on the individual conformational space accessible by a ligand. (4) does not necessarily agree with the protonation state predicted from pka calculations.
Performance of non-equilibrium TMD. In recent years, several other novel methods have been established for fast and efficient computation of binding kinetics 12, 20, 66, [70] [71] [72] (see refs. 73,74 for reviews), and our approach presented here shares similarities with methods based on metadynamics 12 and steered MD. 69 As a prerequisite, we need to have initial information on unbinding pathways to create a suitable reaction coordinate to apply the target bias, as can be provided by other methods. 20, 66, 75 It was recently shown that TMD simulations can be used to effectively push a molecular system of choice along a reaction coordinate that correctly mimics the pathway taken under equilibrium conditions. 56 Besides the results presented here, we found that proteins with challenging unbinding pathways pose a problem for our non-equilibrium TMD method, as a similar investigation with ligands bound to the b2 adrenergic receptor 70 Secondly, the non-equilibrum work rapidly converges (see Figure S6 ), 58 and each simulation by definition results in an unbinding event, which reduces the necessary number of simulations to a number well below that for Markov State Model creation. 74 Thirdly, we do not change the full system Hamiltonian, but merely add a perturbation, avoiding artifacts such as protein unfolding that appear in smoothed/scaled MD. 72, 75 The last strength is that according to the works of Jarzynski, 64 <W> is directly related to the free energy along the pathway, as shown in equation (2).
This connection allows the development of methods to directly calculate the equilibrium free energy profile during unbinding from non-equilibrium simulations, 58 which we will use in the future to investigate the predictions from our linear model given in Equation (4) concerning different dissipation profiles and the individual protonation states of ligands along the unbinding pathway.
Conclusion and future perspective
To elucidate the molecular determinants for unbinding kinetics, we here combined preexisting and novel data from SPR binding kinetics measurements and X-ray crystallography with nonequilibrium targeted MD simulations on the N-terminal domain of Hsp90 for two compound series.
The non-equilibrium work <W> obtained from TMD simulations converges quickly, and is a promising predictor for slowly unbinding compounds. We found ligand conformational changes and nonbonded protein-ligand interactions as molecular discriminators for unbinding rates. As our interpretation of the mean non-equilibrium work <W> as score for koff by use of Equation (4) is based on the Jarzynski equality, 64 we potentially can calculated the unbinding free energy profile directly from <W>. Indeed, we recently showed for a NaCl/water test system that such a correction can readily be achieved via dissipation-corrected targeted MD simulations. 58 As this approach additionally yields friction profiles, we will aim to use the resulting information to carry our Langevin Dynamics calculations 76 for the prediction of absolute ligand unbinding kinetics.
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